Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ambrose

Showing results (211-220 of 250) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|August 30, 2017
Pharmacological Basis of CD101 Efficacy: Exposure Shape MattersElizabeth A Lakota, Justin C Bader, Voon Ong, et al.
Human Molecular Genetics|March 18, 2014
The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutationsKyu Sang Joeng, Yi-Chien Lee, Ming-Ming Jiang, et al.
Oncotarget|August 26, 2015
ZIP4 silencing improves bone loss in pancreatic cancerQiang Zhang, Xiaotian Sun, Jingxuan Yang, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2022
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility BreakpointsS M Bhavnani, M Trang, D C Griffith, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection modelBrian Vanscoy, Rodrigo E Mendes, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease|December 17, 2008
Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpointsPaul G Ambrose, Alison K Meagher, Julie A Passarell, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infectionsScott Van Wart, Luann Phillips, Elizabeth A Ludwig, et al.
Acta Pharmaceutica Sinica. B|October 24, 2025
Dissecting the effects of <sup>223</sup>Radium on the bone microenvironmentSergio Barrios, Elisa Serafini, Ludovica La Posta, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 12, 2026
Bone phenotype in a mouse model of Classical Ehlers Danlos syndrome with Col5a1 haploinsufficiencyKeren Machol, Catherine G Ambrose, Deidre N Meyers, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2020
Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 DataElizabeth A Lakota, Scott A Van Wart, Michael Trang, et al.
Pageof 25

Showing results (211-220 of 250) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|August 30, 2017
Pharmacological Basis of CD101 Efficacy: Exposure Shape MattersElizabeth A Lakota, Justin C Bader, Voon Ong, et al.
Human Molecular Genetics|March 18, 2014
The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutationsKyu Sang Joeng, Yi-Chien Lee, Ming-Ming Jiang, et al.
Oncotarget|August 26, 2015
ZIP4 silencing improves bone loss in pancreatic cancerQiang Zhang, Xiaotian Sun, Jingxuan Yang, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2022
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility BreakpointsS M Bhavnani, M Trang, D C Griffith, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection modelBrian Vanscoy, Rodrigo E Mendes, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease|December 17, 2008
Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpointsPaul G Ambrose, Alison K Meagher, Julie A Passarell, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infectionsScott Van Wart, Luann Phillips, Elizabeth A Ludwig, et al.
Acta Pharmaceutica Sinica. B|October 24, 2025
Dissecting the effects of <sup>223</sup>Radium on the bone microenvironmentSergio Barrios, Elisa Serafini, Ludovica La Posta, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 12, 2026
Bone phenotype in a mouse model of Classical Ehlers Danlos syndrome with Col5a1 haploinsufficiencyKeren Machol, Catherine G Ambrose, Deidre N Meyers, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2020
Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 DataElizabeth A Lakota, Scott A Van Wart, Michael Trang, et al.
Pageof 25